Industry & Business

Fastnet to abandon oil and gas for biopharma

 Breaking News
  • Largest Ever European Investment Bank Support in Ireland The European Investment Bank is to provide a loan of €490 million to support construction of the new children’s hospital in Dublin. This represents the largest ever financial engagement by the European Union’s long-term lending institution in Ireland and the EIB’s first backing for a hospital in the country. The new children’s hospital project includes two [...]...
  • Strabane Manufacturer to Invest Over £7 Million in Ambitious Expansion Strabane-based Fabplus is planning to more than double its workforce and turnover with support from Invest Northern Ireland. The investment is part of a three year expansion plan to increase its market share in the Republic of Ireland and Great Britain, and gain a foothold in mainland Europe and Scandinavia. Recruitment is underway to employ 83 additional staff at [...]...
  • PM Group Appoints a New Non-Executive Director Michael McNicholas has been appointed as a Non-Executive Director of Project Management Holdings (PM Group), the Irish headquartered international project delivery specialists. Michael McNicholas. Michael has over 35 years’ experience in senior leadership positions in the public and private sectors. He is the former CEO of Ervia, NTR plc and Managing Director of ESB International.  During his [...]...
  • Center Parcs Signs Contract With John Sisk & Son As construction activity on the much anticipated €233 million Center Parcs Longford Forest resort in County Longford ramps up, the company has announced it has formally awarded two major construction contracts to Dublin-based construction firm John Sisk & Son. The contracts for the construction of the 470 lodges and 30 apartments as well as the state-of-the-art centre [...]...
  • Medi-Shower Invests in Innovation to Drive Export Growth Multi-award-winning manufacturer Medi-Shower has created ‘smart showerhead’ technology which can reduce the risk of Legionnaires disease. The cutting edge product, developed with R&D support from Invest Northern Ireland is designed to meet the high requirements for hygiene within the healthcare sector. It reduces the risk of waterborne infection from bacteria that can build up due to poor design [...]...

Fastnet to abandon oil and gas for biopharma

Fastnet to abandon oil and gas for biopharma
August 12
09:01 2015

Fastnet Oil & Gas, the exploration company listed on the Dublin and London alternative investment markets, is to seek shareholder approval to switch to the biopharma sector and abandon its activities off the coasts of Ireland and Morocco.
The company, which is chaired by one of the founding directors of Merrion Corporate Finance, Cathal Friel, and has offices in Dublin and London, began trading on the AIM and ESM markets in June 2012, when it raised €10 million.
In a statement it said it had a cash balance of $15.9 million at the end of July last and had successfully reduced its annual overheads by more than 40 per cent, since December 2014, to $1.9 million. If its change of function is supported at a general meeting in London on August 28th, then it intends to reduce its annual running costs to $0.6 million.
Its chief executive, Carol Law, will resign if the proposal is approved, and other board changes are also likely, the company said.
The decision to abandon the exploration sector flows from the worldwide decline in oil and gas prices and the associated adverse sentiment towards small cap oil and gas concerns, it said.
“The board believes that the healthcare industry, particularly the biopharma sector, is experiencing strong momentum and there exist significant M&A and value creation opportunities for both small and large cap companies.”
The board also believes it has access to an international pipeline of such opportunities, the company said in its statement. It will initially focus on opportunities in Europe, it said.
Fastnet, which will change its name to Fastnet Equity plc, intends to take an equity interest in a proposed investment that is likely to be a majority position to 100 per cent, and said that its financial resources are likely to be invested in potentially one or more investments in a single transaction which will be deemed a reverse takeover.
A failure to effect a transaction within twelve months of the general meeting would lead to trading in the company’s ordinary shares being suspended.

About Author



Related Articles

New Subscriber

Subscribe Here


National Manufacturing Conference & Exhibition 2016

NIBRT Springboard Success Stories

Upcoming Events

  • No upcoming events
AEC v1.0.4